Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia

Suthahar Ariaratnam, Ambigga Devi, Gurpreet Kaur, Dhachayani Sinniah, Adlina Suleiman, Maniam Thambu, Fuad Ismail

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

This paper was prompted by the necessity to investigate the relationship between psychiatric morbidity and survival of cancer patients. Eighty newly diagnosed treatment-naive patients with cancer were prospectively studied using self-administered questionnaires. Subsequent follow-ups were carried out at 0.5 year and between 1 to 2 years. The prediction of survival time was determined using Cox model. Depression (p = 0.001), stage 4 cancer disease (p = 0.016), neurological (p = 0.032), gastrointestinal tract (p = 0.04), head & neck (p = 0.011), gynecological (p = 0.005) and bone & soft tissue (p = 0.030) malignancies were independent and statistically significant prognostic factor of survival. Depressed patients have almost four fold greater risk of dying than non-depressed patients. Patients with stage 4 cancer illness have five fold greater risk of dying than patients with stage 1 disease. Patients with neurological, gynecological, head and neck, bone & soft tissue and gastro intestinal tract malignancies were found to have approximately thirty-six, twenty-five, twenty-two, sixteen and seven fold greater risk of dying, respectively when compared to subjects with genitourinary cancers.

Original languageEnglish
Pages (from-to)113-116
Number of pages4
JournalBiomedical Research
Volume19
Issue number2
Publication statusPublished - May 2008

Fingerprint

Oncology
Malaysia
Psychiatry
Morbidity
Survival
Bone
Patient treatment
Tissue
Neoplasms
Therapeutics
Neck
Head
Urogenital Neoplasms
Bone and Bones
Proportional Hazards Models
Gastrointestinal Tract

Keywords

  • Cancer patients
  • Psychiatric morbidity
  • Survival
  • Treatment-naive

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Ariaratnam, S., Devi, A., Kaur, G., Sinniah, D., Suleiman, A., Thambu, M., & Ismail, F. (2008). Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia. Biomedical Research, 19(2), 113-116.

Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia. / Ariaratnam, Suthahar; Devi, Ambigga; Kaur, Gurpreet; Sinniah, Dhachayani; Suleiman, Adlina; Thambu, Maniam; Ismail, Fuad.

In: Biomedical Research, Vol. 19, No. 2, 05.2008, p. 113-116.

Research output: Contribution to journalArticle

Ariaratnam, S, Devi, A, Kaur, G, Sinniah, D, Suleiman, A, Thambu, M & Ismail, F 2008, 'Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia', Biomedical Research, vol. 19, no. 2, pp. 113-116.
Ariaratnam S, Devi A, Kaur G, Sinniah D, Suleiman A, Thambu M et al. Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia. Biomedical Research. 2008 May;19(2):113-116.
Ariaratnam, Suthahar ; Devi, Ambigga ; Kaur, Gurpreet ; Sinniah, Dhachayani ; Suleiman, Adlina ; Thambu, Maniam ; Ismail, Fuad. / Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia. In: Biomedical Research. 2008 ; Vol. 19, No. 2. pp. 113-116.
@article{b24363bce99e4d5685330a43cedc3fc0,
title = "Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia",
abstract = "This paper was prompted by the necessity to investigate the relationship between psychiatric morbidity and survival of cancer patients. Eighty newly diagnosed treatment-naive patients with cancer were prospectively studied using self-administered questionnaires. Subsequent follow-ups were carried out at 0.5 year and between 1 to 2 years. The prediction of survival time was determined using Cox model. Depression (p = 0.001), stage 4 cancer disease (p = 0.016), neurological (p = 0.032), gastrointestinal tract (p = 0.04), head & neck (p = 0.011), gynecological (p = 0.005) and bone & soft tissue (p = 0.030) malignancies were independent and statistically significant prognostic factor of survival. Depressed patients have almost four fold greater risk of dying than non-depressed patients. Patients with stage 4 cancer illness have five fold greater risk of dying than patients with stage 1 disease. Patients with neurological, gynecological, head and neck, bone & soft tissue and gastro intestinal tract malignancies were found to have approximately thirty-six, twenty-five, twenty-two, sixteen and seven fold greater risk of dying, respectively when compared to subjects with genitourinary cancers.",
keywords = "Cancer patients, Psychiatric morbidity, Survival, Treatment-naive",
author = "Suthahar Ariaratnam and Ambigga Devi and Gurpreet Kaur and Dhachayani Sinniah and Adlina Suleiman and Maniam Thambu and Fuad Ismail",
year = "2008",
month = "5",
language = "English",
volume = "19",
pages = "113--116",
journal = "Biomedical Research",
issn = "0970-938X",
publisher = "Scientific Publishers of India",
number = "2",

}

TY - JOUR

T1 - Psychiatric morbidity and survival in newly diagnosed treatment-naive cancer patients - A Study from Malaysia

AU - Ariaratnam, Suthahar

AU - Devi, Ambigga

AU - Kaur, Gurpreet

AU - Sinniah, Dhachayani

AU - Suleiman, Adlina

AU - Thambu, Maniam

AU - Ismail, Fuad

PY - 2008/5

Y1 - 2008/5

N2 - This paper was prompted by the necessity to investigate the relationship between psychiatric morbidity and survival of cancer patients. Eighty newly diagnosed treatment-naive patients with cancer were prospectively studied using self-administered questionnaires. Subsequent follow-ups were carried out at 0.5 year and between 1 to 2 years. The prediction of survival time was determined using Cox model. Depression (p = 0.001), stage 4 cancer disease (p = 0.016), neurological (p = 0.032), gastrointestinal tract (p = 0.04), head & neck (p = 0.011), gynecological (p = 0.005) and bone & soft tissue (p = 0.030) malignancies were independent and statistically significant prognostic factor of survival. Depressed patients have almost four fold greater risk of dying than non-depressed patients. Patients with stage 4 cancer illness have five fold greater risk of dying than patients with stage 1 disease. Patients with neurological, gynecological, head and neck, bone & soft tissue and gastro intestinal tract malignancies were found to have approximately thirty-six, twenty-five, twenty-two, sixteen and seven fold greater risk of dying, respectively when compared to subjects with genitourinary cancers.

AB - This paper was prompted by the necessity to investigate the relationship between psychiatric morbidity and survival of cancer patients. Eighty newly diagnosed treatment-naive patients with cancer were prospectively studied using self-administered questionnaires. Subsequent follow-ups were carried out at 0.5 year and between 1 to 2 years. The prediction of survival time was determined using Cox model. Depression (p = 0.001), stage 4 cancer disease (p = 0.016), neurological (p = 0.032), gastrointestinal tract (p = 0.04), head & neck (p = 0.011), gynecological (p = 0.005) and bone & soft tissue (p = 0.030) malignancies were independent and statistically significant prognostic factor of survival. Depressed patients have almost four fold greater risk of dying than non-depressed patients. Patients with stage 4 cancer illness have five fold greater risk of dying than patients with stage 1 disease. Patients with neurological, gynecological, head and neck, bone & soft tissue and gastro intestinal tract malignancies were found to have approximately thirty-six, twenty-five, twenty-two, sixteen and seven fold greater risk of dying, respectively when compared to subjects with genitourinary cancers.

KW - Cancer patients

KW - Psychiatric morbidity

KW - Survival

KW - Treatment-naive

UR - http://www.scopus.com/inward/record.url?scp=51049113202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51049113202&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 113

EP - 116

JO - Biomedical Research

JF - Biomedical Research

SN - 0970-938X

IS - 2

ER -